Our Team

Amélie Quesnel-Vallée is the Inaugural Chair and Professor in the Department of Equity, Ethics and Policy (Faculty of Medicine and Health Sciences) and a Professor in the Department of Sociology (Faculty of Arts). She is the founding Director of the McGill Observatory on Health and Social Services Reforms and a founding member of the McGill Center on Population Dynamics. Finally, she also founded and is Executive Director of CAnD3 (https://mcgill.ca/cand3/), an international consortium of 38 academic, government, private and non-profit organizations delivering training in support of evidence-based decision making.

Quesnel-Vallée’s research examines the contribution of policies to social inequalities in health over the life course and has been recognized through awards from professional associations including the American Sociological Association, the Population Association of America, and the American Public Health Association. She is a two-time Fulbright Foundation awardee, most recently of a Distinguished Chair (2020). She is a Past-President of the Canadian Population Society and of the International Sociological Association’s Research Committee on the Sociology of Health. She has demonstrated experience in providing strategic advice to several complex organizations, notably the Canadian Institutes of Health Research, where she served as a board member for six years, and held leadership roles such as the inaugural Chair of the Standing Committee on Science (2022-2024) and as a Member of the Executive Committee (2021-2024). Committed to furthering public understanding of science, Quesnel-Vallée is frequently sought by media outlets such as National Public Radio, the New York Times and Business Week.

Dr. Carpentier is an endocrinologist and researcher, and scientific director of the CHUS Research Centre and full professor in the Faculty of Medicine and Health Sciences at the Université de Sherbrooke. He is the Director of the Canada Research Chair in Molecular Imaging of Diabetes. He is also the Co-Scientific Director of the CIHR Diabetes Action Canada Research Network and the CIHR Canada-Netherlands Type 2 Diabetes Research Consortium (TIMED). His research program, funded by CIHR and Diabetes Canada, is developing molecular imaging and metabolic tracer methods to assess the involvement of fat metabolism in type 2 diabetes and fatty metabolic liver disease. Dr. Carpentier has published more than 208 scientific articles cited more than 24,285 times. Since January 2022, he has been co-director of the Pôle universitaire de santé numérique de l’Estrie.